INS and metabolic syndrome: Accumulating evidence suggests that IGF-BP1 and IGF-BP2 may increase insulin sensitivity directly [18] and cluster with components of the metabolic syndrome in obese children [19] Hence, these IGF-BPs may serve as a useful biomarker of insulin sensitivity in early childhood [20].